BNET Industries

Immunicon Corp.

(IMMC) is in the Health Care Industry

Last Fiscal Year Sales:$16.0M
  • Public
  • US
Dow Jones Description

Our business principally involves the development, manufacture, marketing and sale of proprietary cell-based diagnostic and research products and certain service activities with a primary focus on cancer. We believe that our products can provide significant clinical benefits by giving physicians better information to understand, treat, monitor and predict outcomes for their patients. Our technologies can identify, count and characterize circulating tumor cells, or CTCs, and other rare cells present in a blood sample from a patient. We also employ our technologies to provide analytical services to pharmaceutical and biotechnology companies to assist them in the development of new therapeutic agents. We operate in one business segment, have our principal offices in Huntingdon Valley, Pennsylvania, and maintain a small research and clinical development laboratory in the Netherlands. In August 2000, we entered into a Development, License and Supply Agreement, or the DLS Agreement, with Ortho-Clinical Diagnostics, or OCD, a Johnson & Johnson company, which subsequently assigned all rights and obligations under the agreement to Veridex, LLC, or Veridex, also a Johnson & Johnson company. Under the terms of this agreement, we granted to Veridex a worldwide exclusive license within the field of cancer to commercialize cell analysis products incorporating our technologies.

President & Chief Executive Officer
Byron D. Hewett
Number of Employees 107
Contact Information

3401 Mason Mill Rd, Ste 100

Huntingdon Valley, Pennsylvania 19006

immunicon.com

(215) 830-0777

NAICS Code Analytical Laboratory Instrument Manufacturing: 334516

News & Analysis

cell and immunicon corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
Byron D. Hewett President & Chief Executive Officer
James L. Wilcox Senior Vice President and Clo
Leon Terstappen Senior Vice President, Res & Development & Chief Scientific Officer
Carrie Mulherin Vice President, Marketing
James M. Wilcox Vice President
John Verrant Vice President, Engineering
Katharine Hawes Vice President, Manufacturing
Mark Connelly Vice President, Reagent Development
Michael Kagan Vice President, Operations
Peter Scott Vice President, Quality Assurance & Regulatory Affairs
Teresa Lipcsey Vice President & Controller
Ken Berlin General Manager
Gerald V Doyle Senior Director of Clinical Research
Allen J. Lauer Director
David R Dantzker Advisory Member
Seth Rudnick Director

Board of Directors

Name (plus bio) Position
Brian Geiger Chair
Zola P. Horovitz Chair
Jonathan Cool Board of Directors
Stephen Bloch Board Observer

Organization Position Status
Immunicon Corporation President & Chief Executive Officer Current
Immunicon Corporation Board of Directors Current
Immunicon Corporation Chief Operating Officer Former
Cancer Products General Manager Former
University of Virginia B.S. Former

Organization Position Status
Immunicon Corporation Senior Vice President and Clo Current

Organization Position Status
Immunicon Corporation Senior Vice President, Res & Development & Chief Scientific Officer Current

Organization Position Status
Immunicon Corporation Vice President, Marketing Current

Organization Position Status
Immunicon Corporation Vice President Current

Organization Position Status
Immunicon Corporation Vice President, Engineering Current

Organization Position Status
Immunicon Corporation Vice President, Manufacturing Current

Organization Position Status
Immunicon Corporation Vice President, Reagent Development Current

Organization Position Status
Immunicon Corporation Vice President, Operations Current
Wentworth Institute of Technology Degrees Former

Organization Position Status
Immunicon Corporation Vice President, Quality Assurance & Regulatory Affairs Current

Organization Position Status
Immunicon Corporation Vice President & Controller Current

Organization Position Status
Immunicon Corporation General Manager Current

Organization Position Status
Immunicon Corporation Senior Director of Clinical Research Current
Chester Springs Family Dentistry Dentist Current
Thomas Jefferson University Degree In Biochemistry Former
Temple University School of Dentistry Former

Brian J. Geiger , 63, has served as one of our directors since August 2000. Mr. Geiger serves as Chair of our Audit and Compliance Committee and serves on our Compensation Committee and Nominating and Governance Committee. Mr. Geiger served as Executive Vice President and Chief Financial Officer of Ascendia Brands, Inc., a manufacturer, marketer and distributor of health and beauty aid products from May 2004 until July 2006. From 1997 to March 2004, Mr. Geiger served as Executive Vice President and Chief Financial Officer of Claneil Enterprises, Inc., a private equity firm. Mr. Geiger holds a B.A. in Economics from Rutgers University, an M.B.A. in Finance from Seton Hall University, and has been a C.M.A. since 1986.

Organization Position Status
Immunicon Corporation Chair Current
Opinion Research Corporation Director Current
Ascendia Brands, Inc. Chief Financial Officer Former
The Liposome Company, Inc. Chief Financial Officer Former
Claneil Enterprises, Inc. Chief Financial Officer Former
Ascendia Brands, Inc. Executive Vice President Former
Claneil Enterprises, Inc. Executive Vice President Former
The Liposome Company, Inc. Vice President, Finance Former
Hermes Group LLC Former
Johnson & Johnson Former
Seton Hall University M.B.A. Former
Rutgers University B.A. Former

Organization Position Status
Sage Healthcare, Ltd. Current
Phyton, Inc. Chairman Current
GenVec, Inc. Chairman Current
Immunicon Corporation Chair Current
Genaera Corporation Chairman Current
BioCryst Pharmaceuticals, Inc. Director, Chairman of The Board Current
Xintria Pharmaceutical Corporation Member of Dov Pharmaceuticals Board of Directors Current
Palatin Technologies Inc. Board of Directors Current
Avigen, Inc. Director Current
BioCryst Pharmaceuticals, Inc. Director Current
NitroMed, Inc. Director Current
International Fight League, Inc. Director Current
DOV Pharmaceutical, Inc. Director Current
Immunicon Corporation Director Current
NitroMed, Inc. Committee Member Current
Avigen, Inc. Vice President, Business Development Former
Bristol-Myers Squibb Company Vice President, Business Development and Planning Former
Bristol-Myers Squibb Company Associate Director Former
Bristol-Myers Squibb Company Liaison Former
Phyton, Inc. Director Former
Princeton University Board of Directors Former
GenVec, Inc. Director Former
University of Pittsburgh Ph.D. In Pharmacology Former
University of Pittsburgh M.S. In Pharmacology Former
University of Pittsburgh B.S. In Pharmacy Former

Organization Position Status
Varian, Inc. Chairman Current
Intermec, Inc. Chairman Current
Immunicon Corporation Director Current
Polymer Laboratories, Ltd. Board of Directors Current
Varian, Inc. Chief Executive Officer Former
Varian, Inc. President Former
U.S. Navy commissioned officer Former
Varian, Inc. Board of Directors Former
University of California, Berkeley MBA Former
Stanford University B.S. degree in electrical engineering Former

Organization Position Status
Wheatley Partners II Annex Fund LP Manager Current
Nexray Director Current
Immunicon Corporation Advisory Member Current
Advanced Biohealing Board of Directors Current
Q-Rna, Inc. Board Member Current
Neuro-Hitech, Inc. Director Current
North Shore Long Island Jewish Health System President Former
Indevus Pharmaceuticals, Inc. - NJ Board of Directors Former
State University of New York at Buffalo M.D. Former
The State University of New York M.D. Former
New York University B.A. In Biology Former
State University of New York at Buffalo Degree Former

Organization Position Status
Immunicon Corporation Board of Directors Current
Harvard University M.B.A. Former
Stanford University B.A. Former

Prior to joining Canaan, Seth served as CEO and Chairman at CytoTherapeutics (CTII). Before that, he helped start and served as head of R&D for Ortho Biotech, a division of Johnson & Johnson. In that role, he led the development efforts for a portfolio of projects which are still responsible for significant Johnson and Johnson revenues. He began his industrial career at Schering-Plough where he ran clinical trials for the alpha interferon project, and later transferred to Biogen to run that company's pharmaceutical development efforts. His academic career began when he served on the medical and public health faculty at Chapel Hill. Seth is a Clinical Professor of Medicine at Chapel Hill where he teaches and advises the faculty on biotechnology issues. Recently, Seth was included in the 2006 Midas List, a prominent venture capital listing which ranks the best dealmakers in high-tech and life sciences.

Organization Position Status
Canaan Partners Venture Partner Current
University of North Carolina, Chapel Hill Clinical Professor of Medicine Current
Liquidia Technologies Inc Chairman Current
VaxInnate Corporation Board of Directors Current
Northstar Neuroscience, Inc. Director Current
Immunicon Corporation Director Current
Chimerix, Inc. Director Current
Cytotherapeutics, Inc. CEO Former
Ortho Biotech Inc. Head of R&D Former
Johnson & Johnson Former
Schering-Plough Corporation Former
Cytotherapeutics, Inc. Chairman Former
University of Virginia M.D. Former
University of Virginia Degree Former

Organization Position Status
Marinus Pharmaceuticals Inc. Chairman Current
CombinatoRx, Incorporated Board Observer Current
Immunicon Corporation Board Observer Current
Amicus Therapeutics, Inc. Board Member Current
Genaissance Pharmaceuticals, Inc. Board Observer Current
Tele-Rad Inc Co-Founder Former
Omnisonics Medical Technologies, Inc. Medical Director Former
Arthur D. Little, Inc. Strategic Consultant Former
Harvard University MA Former
Dartmouth College Ab Degree Former
University of Rochester Medical Degree Former

Executive News

  • Chimerix Raises $16.1 Million in Series E Financing

    PR Newswire - 8/11/09 - View Story

advertisement
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement